Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib  

Oleh:

Cataldo, Vince D. ; Gibbons, Don L. ; Perez-Soler, Roman ; Quintás-Cardama, Alfonso

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 364 no. 10 (Mar. 2011), page 947-955.
Topik: CANCER; Liver Metastases Develop

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2011.01 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

A 64-year-old woman who has never smoked receives the diagnosis of stage I adenocarcinoma of the lung and undergoes right upper lobectomy. One year later, bone and liver metastases develop. She is treated with carboplatin, paclitaxel, and bevacizumab, but progressive bone metastases are noted after 6 weeks of therapy. An oncologist recommends the initiation of erlotinib therapy.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali